Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Thumbnail

Researchers team virtual reality with AI to train new surgeons

Machine learning can be combined with virtual or augmented reality to train surgery residents in sensitive spinal procedures.

Thumbnail

FDA grants ‘breakthrough’ designation to ultrasound AI product

Software that uses AI to make cardiac-ultrasound experts of healthcare workers with no prior ultrasound experience has received “Breakthrough Device” designation from the FDA.

Thumbnail

Cancer research involving AI long on predictions, short on outcomes

Worldwide, research is booming around AI applications for predicting and treating cancer with ever more precise and personalized approaches. However, a new literature review has found a shortfall of AI-inclusive studies looking at cancer outcomes and survivorship.

Thumbnail

Deep-learning algorithm diagnoses pneumonia in 10 seconds

If a newly tested AI system for reading chest X-rays achieves widespread adoption, patients presenting in the ER with symptoms of pneumonia can expect an up or down diagnosis—and with it the start of a treatment plan—in 10 seconds.

Algorithmic approach 90% accurate at diagnosing pediatric acute appendicitis

Researchers in Germany have developed an AI-based method for identifying pediatric acute appendicitis using biomarkers like blood and protein readings obtained in routine lab tests.

Thumbnail

AI a key component in $100M global health initiative

Several major charitable organizations are banding together to prevent 6 million deaths in 10 countries by 2030 using Big Data to provide precision medicine.

Amazon pilots virtual care clinic for employees

In another sign of its trek into the healthcare space, Amazon has opened a virtual care clinic for its Seattle-based employees, with in-home or in-office follow-ups.

Thumbnail

IBM Watson partnering with contrast company on prostate AI

Aiming to develop and market AI algorithms for diagnosing prostate cancer on MRI scans, IBM Watson Health is working with Guerbet, a France-based maker of contrast agents used in medical imaging.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”